SECsense Logo

Traws Pharma, Inc. 8-K Report: Key Updates from December 29, 2024

$TRAW
Form 8-K
Filed on: 2024-12-31
Source
Traws Pharma, Inc. 8-K Report: Key Updates from December 29, 2024

Based on the provided XML data from the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Traws Pharma, Inc.
  • CIK (Central Index Key): 0001130598
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-36020
  • Tax Identification Number: 22-3627252
  • Address: 12 Penns Trail, Newtown, PA 18940
  • Phone Number: 267-759-3680
  1. Report Type:
  • Filing Type: 8-K (current report)
  1. Filing Date:
  • Date of Report: December 29, 2024
  1. Financial Information:
  • Stock Information:
    • Common Stock Par Value: $0.01 per share
    • Trading Symbol: TRAW
    • Exchange: NASDAQ
  1. Context and Measurement:
  • Reporting Period: The data is as of December 29, 2024.
  • Currency: USD (U.S. Dollar)
  • Unit of Measurement: Shares

Insights:

  • The report pertains to a significant event or update for Traws Pharma, as indicated by the filing of an 8-K, which is typically used to disclose important company events.
  • The company is publicly traded on NASDAQ, suggesting it is subject to SEC regulations and is likely to have a substantial market presence.
  • The mention of common stock and par value indicates the company is maintaining traditional equity structures, which can be relevant for investors looking at equity investment opportunities.
  • The report’s date indicates that this information is current as of late 2024, providing a snapshot of the company's status at that time.

This information can assist investors and analysts in evaluating Traws Pharma's current market position and any significant developments that may impact its operations or financial standing.